Pavlik Harness for Developmental Dysplasia of the Hip (DDH)
Treatment for Congenital Musculoskeletal And Limb Anomalies
Typical Dosage: Continuous wear of harness, adjusted weekly
Effectiveness
98%
Safety Score
88%
Clinical Trials
200
Participants
30K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
88
DangerousModerateSafe
Treatment Details
Dosage Range
Continuous wear of harness, adjusted weekly
Time to Effect
6-12 weeks for hip stabilization
Treatment Duration
6-12 weeks full-time, then potentially part-time for another 4-6 weeks
Evidence Quality
HIGHConfidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$800
Side Effect Mgmt:$50
Total Annual:$850
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$15,000/QALY
QALYs Gained
0.9
Outcome-Based Costs
Cost per Responder
$867.35
Cost per Remission
$894.74
Comparison vs Surgical Reduction for DDH
Cost Difference
$-19,150/year
Less expensive
QALY Difference
+0.30 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Pavlik Harness for Developmental Dysplasia of the Hip (DDH) Outcomes
for Congenital Musculoskeletal And Limb Anomalies
Efficacy Outcomes
Overall Effectiveness
+98%
Response Rate
+98%
Remission Rate
+95%
Common Side Effects
Skin irritation
+10%
Femoral nerve palsy (temporary)
+1%
Avascular necrosis of femoral head (rare)
+0.5%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov